Becton Dickinson & Co.
BDX
ISIN null / Valor 912061
Becton Dickinson & Co.
UMushroom community rating:
About company
Becton Dickinson & Co. is a leading global medical technology company focused on improving medical discovery, diagnostics, and healthcare delivery. With a workforce of 75,000 employees, the company develops innovative technology, services, and solutions to enhance clinical therapy, improve clinical processes, and advance diagnostics and therapeutics. BD has a presence in nearly every country and collaborates with organizations worldwide to address global health challenges. The company's acquisition of CareFusion in 2015 expanded its expertise in reducing medication errors and preventing healthcare-associated infections. BD's Life Sciences segment offers solutions for infectious disease and cancer, from discovery to diagnosis, to advance scientific and clinical outcomes.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
66122 M
Market cap (USD)
2,986,914
Daily traded volume (Shares)
227.8 / 225.05
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
